<DOC>
	<DOCNO>NCT00193427</DOCNO>
	<brief_summary>This trial design study role docetaxel/gemcitabine , active relatively non-toxic combination advance NSCLC . This study help good define optimal preoperative regimen patient resectable NSCLC . Since drug potent radio-sensitizers , concurrent use radiation therapy weekly dos may produce radio-sensitization , also considerable antitumor efficacy .</brief_summary>
	<brief_title>Preoperative Therapy Patients With Stages IB , II , IIIA , Selected IIIB Patients With Non-Small Cell Lung Cancer</brief_title>
	<detailed_description>Upon determination eligibility , patient receive : Pre-operative - Docetaxel - Gemcitabine Post-operative - Docetaxel - Carboplatin - Radiation Therapy Patients stage IB II NSCLC achieve clear margin receive therapy . Patients incomplete resection , resection margin T3 tumor positive close , stage IIIA AND IIIB NSCLC disease judge unresectable preoperative chemotherapy receive postoperative treatment</detailed_description>
	<mesh_term>Lung Neoplasms</mesh_term>
	<mesh_term>Carcinoma , Non-Small-Cell Lung</mesh_term>
	<mesh_term>Gemcitabine</mesh_term>
	<mesh_term>Docetaxel</mesh_term>
	<mesh_term>Carboplatin</mesh_term>
	<criteria>To include study , must meet following criterion : Histologically confirm nonsmall cell lung cancer Must operable candidate Clinical stage IB , II , select III nonsmall cell lung cancer eligible Measurable evaluable disease Able perform activity daily live minimal assistance Must &gt; 18 year age Adequate bone marrow , liver kidney No previous chemotherapy radiation therapy nonsmall cell lung cancer Moderate severe peripheral neuropathy Understand nature study give write informed consent . You participate study follow apply : Stage IV disease History prior malignancy within five year Women pregnant breastfeed Please note : There additional inclusion/exclusion criterion . The study center determine meet criterion . If qualify trial , study personnel explain reason . If qualify , study personnel explain trial detail answer question may .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2012</verification_date>
</DOC>